Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Malignant Solid Neoplasm × irinotecan sucrosofate × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 9 Stomach Neoplasms 3 Colorectal Neoplasms 3 Biliary Tract Neoplasms 3 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Wilms Tumor 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Peritoneal Neoplasms 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nasopharyngeal Carcinoma 1 Metastatic Adenocarcinoma of the Pancreas 1 Malignant Ascites 1 Locally Advanced Rectal Cancer 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Specimen Handling 5 Interviews as Topic 4 Standard of Care 3 Practice Guidelines as Topic 3 Methods 3 Educational Status 3 Early Intervention, Educational 3 Biopsy 3 X-Rays 2 trastuzumab biosimilar HLX02 1 pertuzumab 1 erdafitinib 1 copanlisib 1 Verteporfin 1 Trastuzumab 1 Palliative Care 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Magnetic Resonance Spectroscopy 1 Iohexol 1 Health Promotion 1 Exercise Test 1 Carboplatin 1 CT-P6 1 Asian ginseng 1 Art Therapy 1 2C4 antibody 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡